Combined Use of a Novel Cardioplegic Formula With MPS ® Using the MiECC in Isolated CABG Versus OPCABG
- Conditions
- Complication of Extracorporeal CirculationComplication of Coronary Artery Bypass Graft
- Registration Number
- NCT03609723
- Lead Sponsor
- University Hospital, Basel, Switzerland
- Brief Summary
A patient group receiving a novel cardioplegic formula with MPS ® (Myocardial protection system) and using the MiECC (Minimal extracorporeal circulation system) when undergoing coronary artery bypass grafting is compared to a retrospective patient group undergoing Off-pump coronary artery bypass grafting.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 2433
- CABG using MPS® or OPCABG
- use of other colloid solution than Cardioplexol ® for MPS®
- other inventions than CABG
- myocardial infarction <7 days before CABG
- patients denial of data use
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method assessment of cardial biomarkers as high sensitive troponin T (hs-TrT), Creatinkinase (CK) and Creatinkinase myocardial type (CK-MB) perioperative during hospital stay for CABG high sensitive troponin T (hs-TrT), Creatinkinase, (CK) Creatinkinase myocardial type (CK-MB)
- Secondary Outcome Measures
Name Time Method mortality 30 days after CABG death after coronary artery bypass grafting
need for intensive care unit perioperative during hospital stay for CABG duration of stay at intensive care unit
occurence of dysrhythmia perioperative during hospital stay for CABG rhythm disturbance after CABG
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Herzchirurgie University Hospital Basel
🇨🇭Basel, Switzerland
Herzchirurgie University Hospital Basel🇨🇭Basel, Switzerland
